Gimv and Iris Capital sell stake in Human Inference

The exit will have a positive effect of €5.2m (€0.22 per share) on Gimv's €971.1m equity value as reported on 30 September 2012.

Trade buyer Neopost offers mailroom solutions for corporations and is listed on the NYSE Euronext in Paris (NYSE:NEO).

Gimv, Iris Capital and the company's management acquired a 72% stake in Human Inference from Prime Ventures in May 2007. Rabobank provided debt for the deal, which was estimated to be worth less than €25m.

Prime Technology Ventures had acquired the stake for €3.5m in December 2003, also with debt provided by Rabobank, supporting the firm's first management buyout. 

Company
Human Inference is an Arnhem-based data management solutions provider for customer databases. Founded in 1986, the company offers its services to a broad client range, including ABN Amro, Center Parcs, ING and E-On.

People
Winfried van Holland is CEO of Human Inference. Denis Theiry is chairman and CEO of Neopost.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Exits
• Benelux
• Now researching
• Technology
• Gimv
• Netherlands
• NYSE
• Euronext
• Rabobank
• Prime Technology Ventures
• Iris Capital (Part’Com)